Ethereum ETFs Lead July Inflows, Outpacing Bitcoin

Ethereum demonstrated stronger market performance than Bitcoin in July, driven by substantial inflows into its exchange-traded funds (ETFs) and increased corporate accumulation. Ether (ETH) saw a 19% price increase during the month, while Bitcoin (BTC) rose by 8%. This divergence led to the ETH/BTC ratio climbing above 0.030 for the first time in three months, indicating a potential rotation of capital back into Ethereum after a period of underperformance.
US spot Ethereum ETFs recorded $365.17 million in net inflows in July, marking their best month of the year. This contrasts sharply with Bitcoin ETFs, which experienced their weakest inflows since their January launch, attracting only $172.43 million. The surge in ETH ETF demand follows two months of significant outflows totaling over $1 billion. The launch of the Morgan Stanley Ethereum Trust (MSSE) also contributed, attracting assets and leveraging the firm's extensive network of financial advisors.
Despite the positive ETF activity and price action, on-chain indicators present a mixed picture. While some metrics show improvement, they have not yet reached levels typically associated with previous market bottoms relative to Bitcoin. This suggests that while institutional interest in Ethereum is growing, the broader market recovery may still be in its early stages.
This is an AI-assisted summary. Original reporting by CryptoSlate.
Read the originalRelated stories

Bitcoin Recovers on Geopolitical De-escalation
Bitcoin surged by $1,500 as President Trump announced a pause in potential strikes against Iran, signaling a de-escalation of regional tensions and

Strategy Posts Huge Q2 Loss; Coinbase Revenue Dips
Bitcoin treasury firm Strategy recorded an $8.23B Q2 loss, while crypto exchange Coinbase saw revenue fall 19% amid declining trading volumes.

MicroStrategy Signals Shift Away From Bitcoin Accumulation
MicroStrategy's CEO announces a new corporate objective, moving focus from Bitcoin accumulation to stock price targets, sparking analyst criticism.